This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Brian Vastag

JAMA. 2001;286:2934.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Fulfilling a promise made earlier this year, the National Institutes of Health has made public its registry of human embryonic stem cell lines eligible for federal funding. The Web site (http://escr.nih.gov) provides details, where they are available, on 72 stem cell lines from 11 universities and companies in five countries. Researchers can also find grant application instructions.

The 72 lines are in various stages of preparation. Most are listed with little or no additional information. Many of these lines were derived from human embryos not long before the August 9, 2001, deadline set by President Bush.

One cell line at the Wisconsin Alumni Research Foundation, Madison, is frozen in vials and is ready for shipping. According to the site, the cells are positive for cell markers SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase; they are negative for SSEA-1. The stem cells have also passed "quality control . . . [Full Text of this Article]